• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Oncternal Therapeutics Inc (NQ: ONCT )

    7.080 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,517
    Open 7.265
    Bid (Size) 7.000 (1)
    Ask (Size) 8.210 (4)
    Prev. Close 7.080
    Today's Range 6.917 - 7.265
    52wk Range 5.566 - 13.14
    Shares Outstanding 58,711,451
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    ONCT Stock Earnings: Oncternal Therapeutics Beats EPS, Beats Revenue for Q1 2024
    ONCT stock results show that Oncternal Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Insiders Buying Westlake Chemical Partners And 2 Other Stocks
    Although U.S. stocks closed mostly lower on Monday, there were a few notable insider trades. 
    Via Benzinga

    Performance

    YTD
    -36.10%
    -36.10%
    1 Month
    -13.97%
    -13.97%
    3 Month
    -20.89%
    -20.89%
    6 Month
    -7.09%
    -7.09%
    1 Year
    -21.53%
    -21.53%

    More News

    Read More
    ONCT Stock Earnings: Oncternal Therapeutics Misses EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    Recap: Oncternal Therapeutics Q4 Earnings
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    American Airlines To Rally Around 32%? Here Are 10 Top Analyst Forecasts For Monday
    Via Benzinga
    Earnings Outlook For Oncternal Therapeutics
    Via Benzinga
    Earnings Scheduled For March 7, 2024
    Via Benzinga
    Oncternal Therapeutics's Earnings: A Preview
    Via Benzinga
    Top 5 Health Care Stocks That May Crash This Month
    Via Benzinga
    Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Why Ascent Industries Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Crude Oil Rises Over 3%; US Home Prices Increase In October
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Oncternal Therapeutics Reports Patient Death In Mid-Stage Blood Cancer Study Treated With Second Dose Level
    Via Benzinga
    Dow Gains Over 50 Points; Chicago Fed National Activity Index Increases For November
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Promising Preclinical Results From Blood Cancer Propel Oncternal To Buy Rating
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.